1-8 of 8
recurrence risk
Close
Sort by
Journal Articles

IKZF1 alterations are not associated with outcome in 498 adults with B-precursor ALL enrolled in the UKALL14 trial

Rachel J. Mitchell, Amy A. Kirkwood, Emilio Barretta, Laura Clifton-Hadley, Emma Lawrie, SooWah Lee, Daniel Leongamornlert, David I. Marks, Andrew K. McMillan, Tobias F. Menne, Elli Papaemmanuil, Bela Patel, Pip Patrick, Clare J. Rowntree, Nahid Zareian, Krisztina Zuborne Alapi, Anthony V. Moorman, Adele K. Fielding
Journal: Blood Advances
Blood Adv (2021) 5 (17): 3322–3332.
https://doi.org/10.1182/bloodadvances.2021004430
Published: 2021
Includes: Supplemental data
Journal Articles

Naive T-cell depletion in stem cell transplantation

Marie Bleakley
Journal: Blood Advances
Blood Adv (2020) 4 (19): 4980.
https://doi.org/10.1182/bloodadvances.2020001888
Published: 2020
Includes: Supplemental data
Journal Articles

Early peripheral clearance of leukemia-associated immunophenotypes in AML: centralized analysis of a randomized trial

Clinical Trials & Observations
Giacomo Gianfaldoni, Francesco Mannelli, Tamara Intermesoli, Sara Bencini, Damiano Giupponi, Giorgio Farina, Ilaria Cutini, Maria Ida Bonetti, Arianna Masciulli, Ernesta Audisio, Dario Ferrero, Chiara Pavoni, Anna Maria Scattolin, Alberto Bosi, Alessandro Rambaldi, Renato Bassan
Journal: Blood Advances
Blood Adv (2020) 4 (2): 301–311.
https://doi.org/10.1182/bloodadvances.2019000406
Published: 2020
Includes: Supplemental data
Journal Articles

Impact of antithymocyte globulin on outcomes of allogeneic hematopoietic cell transplantation with TBI

Clinical Trials & Observations
Arnon Nagler, Myriam Labopin, Bhagirathbhai Dholaria, Riitta Niittyvuopio, Johan Maertens, Xavier Poiré, Jan Cornelissen, Péter Reményi, Jean Henri Bourhis, Yves Beguin, Ram Malladi, Tessa Kerre, Wilfried Schroyens, Bipin N. Savani, Mohamad Mohty
Journal: Blood Advances
Blood Adv (2019) 3 (13): 1950–1960.
https://doi.org/10.1182/bloodadvances.2019000030
Published: 2019
Includes: Supplemental data
Journal Articles

Predictors of relapse and efficacy of rituximab in immune thrombotic thrombocytopenic purpura

Clinical Trials & Observations
Lova Sun, Johnathan Mack, Ang Li, Justine Ryu, Vivek A. Upadhyay, Lynne Uhl, Richard M. Kaufman, Christopher P. Stowell, Walter S. Dzik, Robert S. Makar, Pavan K. Bendapudi
Journal: Blood Advances
Blood Adv (2019) 3 (9): 1512–1518.
https://doi.org/10.1182/bloodadvances.2019031039
Published: 2019
Includes: Supplemental data
Journal Articles

Predictive value of disease risk comorbidity index for overall survival after allogeneic hematopoietic transplantation

Nelli Bejanyan, Claudio G. Brunstein, Qing Cao, Aleksandr Lazaryan, Celalettin Ustun, Erica D. Warlick, Mukta Arora, John E. Wagner, Daniel J. Weisdorf
Journal: Blood Advances
Blood Adv (2019) 3 (3): 230–236.
https://doi.org/10.1182/bloodadvances.2018018549
Published: 2019
Journal Articles

Evaluating measurable residual disease in acute myeloid leukemia

Clinical Trials & Observations
Farhad Ravandi, Roland B. Walter, Sylvie D. Freeman
Journal: Blood Advances
Blood Adv (2018) 2 (11): 1356–1366.
https://doi.org/10.1182/bloodadvances.2018016378
Published: 2018
Journal Articles

Mutational analysis of disease relapse in patients allografted for acute myeloid leukemia

Lynn Quek, Paul Ferguson, Marlen Metzner, Ikhlaaq Ahmed, Alison Kennedy, Catherine Garnett, Sally Jeffries, Claudia Walter, Kim Piechocki, Adele Timbs, Robert Danby, Manoj Raghavan, Andrew Peniket, Mike Griffiths, Andrew Bacon, Janice Ward, Keith Wheatley, Paresh Vyas, Charles Craddock
Journal: Blood Advances
Blood Adv (2016) 1 (3): 193–204.
https://doi.org/10.1182/bloodadvances.2016000760
Published: 2016
Includes: Supplemental data